首页 › 自身免疫性疾病 › 纽约州 › New York City
New York City NY 自身免疫性疾病临床试验
19项针对 自身免疫性疾病的研究正在 New York City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Memorial Sloan Kettering Cancer Center, New York
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
招募中2/3 期
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
Daratumumab in Primary Antiphospholipid Syndrome
招募中1/2 期
- NYU Langone, New York
- Hospital for Special Surgery, New York
- Weill Cornell, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Memorial Sloan Kettering Cancer Center, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Abatacept for the Treatment of Giant Cell Arteritis
招募中3 期
- Hospital for Special Surgery, New York
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
招募中3 期
- Icahn School of Medicine at Mount Sinai, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- Columbia University Irving Medical Center, New York
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
招募中1/2 期
- Columbia University, New York
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
招募中3 期
- Site Number - 1036, New York
- Site Number - 1034, New York
Autoimmune and Autoinflammatory Genetics Study
招募中观察性研究欢迎健康志愿者
- NYC H+H/Bellevue, New York
- NYU Langone Health, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- 以及另外 3 项
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
招募中1/2 期
- Columbia University, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Montefiore Medical Center, New York
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
招募中1 期
- Columbia University Irving Medical Center, New York
Biologics And Clinical Immunology Cohort at Sinai
招募中观察性研究
- Mount Sinai, New York
Allergy and Immunology Natural History Study
招募中观察性研究欢迎健康志愿者
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
其他城市的 自身免疫性疾病试验
- Houston, TX21 项研究
- Washington, DC19 项研究
- Philadelphia, PA16 项研究
- Durham, NC15 项研究
- Boston, MA13 项研究
- Chicago, IL12 项研究
- Los Angeles, CA12 项研究
- Dallas, TX9 项研究
- Atlanta, GA8 项研究
- Portland, OR8 项研究
- Milwaukee, WI8 项研究
- Cleveland, OH8 项研究
New York City的其他研究
- 乳腺癌136 项研究
- 非小细胞肺癌121 项研究
- 癌症（所有类型）109 项研究
- 前列腺癌103 项研究
- 转移性癌症93 项研究
- 结直肠癌78 项研究
- 卵巢癌69 项研究
- 肺癌60 项研究
- 多发性骨髓瘤60 项研究
- 胰腺癌60 项研究
- 子宫内膜癌52 项研究
- 急性髓系白血病51 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。